Jan Bouchal

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Radical Prostatectomy

Histone Deacetylase

Editorial Comment

Diffuse Large B Cell Lymphoma

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tracey A Perry, Navta Masand, Katerina Vrzalikova, Matthew Richard Pugh, Wenbin Wei, Robert Hollows, Kateřina Bouchalová, Mahdi Nohtani, Eanna Fennell, Jan Bouchal, Pamela Kearns, Paul G Murray
The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma. Cancers 16 (3) (2024)
Tracey A Perry, Navta Masand, Katerina Vrzalikova, Matthew Richard Pugh, Wenbin Wei, Robert Hollows, Kateřina Bouchalová, Mahdi Nohtani, Eanna Fennell, Jan Bouchal, Pamela Kearns, Paul G Murray
The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma. Cancers 16 (3) (2024)
Tracey A Perry, Navta Masand, Katerina Vrzalikova, Matthew Richard Pugh, Wenbin Wei, Robert Hollows, Kateřina Bouchalová, Mahdi Nohtani, Eanna Fennell, Jan Bouchal, Pamela Kearns, Paul G Murray
The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma. Cancers 16 (3) (2024)
Barbora Kvokačková, Radek Fedr, Daniela Kuzilkova, Jan Stuchlý, Adéla Vávrová, Jiří Navrátil, Pavel Fabian, Róbert Ondruššek, Petra Ovesná, Ján Remšík, Jan Bouchal, Tomáš Kalina, Karel Souček
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Molecular oncology (2022)
Mahdi Nohtani, Katerina Vrzalikova, Maha Ibrahim, Judith E Powell, Eanna Fennell, Susan Morgan, Richard Grundy, Keith McCarthy, Sarah Dewberry, Jan Bouchal, Katerina Bouchalova, Pamela Kearns, Paul G Murray
Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL. Cancers 14 (17) (2022)
Martina Karasová, Jiřina Procházková, Zuzana Tylichová, Radek Fedr, Miroslav Ciganek, Miroslav Machala, Zdeněk Dvořák, Barbora Vyhlídalová, Iveta Zůvalová, Jiří Ehrmann, Jan Bouchal, Zdeněk Andrysík, Jan Vondráček
Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells. Cancers 14 (17) (2022)
Milan Král, Pavel Zemla, David Hradil, Hynek Skotak, Igor Hartmann, Katerina Langova, Jan Bouchal, Daniela Kurfurstova
Iodinated Contrast Medium Affects Urine Cytology Assessment: A Prospective, Single-Blind Study and Its Impact on Urological Practice. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Jiřina Hofmanová, Josef Slavík, Miroslav Ciganek, Petra Ovesná, Zuzana Tylichová, Martina Karasová, Ondřej Zapletal, Nicol Straková, Jiřina Procházková, Jan Bouchal, Zdeněk Kolář, Jiří Ehrmann, Monika Levková, Zlatka Hušková, Pavel Skalický, Alois Kozubík, Miroslav Machala, Jan Vondráček
Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells. International journal of molecular sciences 22 (13) (2021)
Alena Mickova, Gvantsa Kharaishvili, Daniela Kurfurstova, Mariam Gachechiladze, Milan Král, Ondrej Vacek, Barbora Pokryvkova, Martin Mistrik, Karel Souček, Jan Bouchal
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade. International journal of molecular sciences 22 (6) (2021)
Zlatka Hušková, Jana Knillova, Zdenek Kolar, Jana Vrbkova, Milan Kral, Jan Bouchal
The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy. Biomedicines 8 (6) (2020)
Ximena Maria Muresan, Jan Bouchal, Zoran Culig, Karel Souček
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance. Cancers 12 (11) (2020)
Šárka Šimečková, Zuzana Kahounová, Radek Fedr, Ján Remšík, Eva Slabáková, Tereza Suchánková, Jiřina Procházková, Jan Bouchal, Gvantsa Kharaishvili, Milan Král, Petr Beneš, Karel Souček
High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells. Scientific reports 9 (1) (2019)
Dusana Majera, Zdenek Skrott, Jan Bouchal, Jirina Bartkova, Dana Simkova, Mariam Gachechiladze, Jana Steigerova, Daniela Kurfurstova, Jan Gursky, Gabriela Korinkova, Karel Cwiertka, Zdenek Hodny, Martin Mistrik, Jiri Bartek
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. The Prostate 79 (4) (2018)